Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-11-004664
Filing Date
2011-07-06
Accepted
2011-07-06 12:44:14
Documents
1
Period of Report
2011-07-01

Document Format Files

Seq Description Document Type Size
1 c66200_form4.html 4  
1 c66200_form4.xml 4 3731
  Complete submission text file 0000930413-11-004664.txt   5532
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ICAHN CAPITAL LP 767 FIFTH AVENUE, SUITE 4700 NEW YORK NY 10153
Business Address
DENNER ALEXANDER J (Reporting) CIK: 0001361754 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 11952391